Company Overview
About Elligo Health Research
Elligo Health Research is a clinical research organization (CRO) and technology company founded in 2016 and headquartered in Austin, Texas, that embeds clinical trials within existing healthcare environments rather than requiring dedicated research centers. The company's model enables practicing physicians and health systems to conduct clinical trials for their own patients by providing the infrastructure, personnel, regulatory expertise, and data integration needed to run trials — without requiring those providers to become stand-alone research sites. This "research-in-care" approach significantly broadens the pool of potential trial sites and patients.
Business Model & Competitive Advantage
Elligo's platform leverages electronic health records (EHRs) to identify patients who meet clinical trial eligibility criteria, dramatically improving the speed and accuracy of patient identification and recruitment — one of the most time-consuming and expensive phases of clinical trial execution. By connecting trial sponsors and CROs with real-world patient populations at the point of care, Elligo reduces the screening failures and slow enrollment that are major contributors to trial delays and cost overruns.
Competitive Landscape 2025–2026
The company has activated more than 850 investigator sites across US health systems, physician groups, and specialty practices, enabling access to diverse patient populations that are often underrepresented in traditional academic medical center-dominated clinical trials. Elligo partners with pharmaceutical companies, biotechs, and CROs that need to accelerate enrollment and improve trial diversity. The company has raised institutional venture funding and been recognized as one of the most innovative companies in clinical research for its approach to decentralizing trial site infrastructure.
Key Differentiators
Strong Challenger
Elligo Health Research is an established challenger with significant market presence and competitive offerings in Life Sciences & BioTech.
Frequently Asked Questions
Similar Brands
Neuralink
Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with pa
Illumina
Illumina was founded in 1998 in San Diego and has grown into the undisputed leader in next-generation sequencing (NGS), with approximately 80% global market share across research and clinical applicat
Cradle
Cradle is a protein design platform using AI to help biotechnology and pharmaceutical companies engineer better proteins — enzymes, antibodies, and therapeutic proteins — with improved stability, acti
BioNTech
BioNTech SE was founded in 2008 in Mainz, Germany by Ugur Sahin, Ozlem Tureci, and Christoph Huber with a mission to harness the immune system for individualized cancer treatment. The company pioneere
Pliant Therapeutics
Pliant Therapeutics develops small molecule integrin inhibitors targeting the pathological tissue scarring (fibrosis) that drives diseases including idiopathic pulmonary fibrosis (IPF), primary sclero
Genentech
Genentech was founded in 1976 in South San Francisco by Herbert Boyer and Robert Swanson, becoming the first company to produce human insulin using recombinant DNA technology and essentially launching
Compare Elligo Health Research with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Elligo Health Research? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Elligo Health Research Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Elligo Health Research vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →